Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep 3;285(36):27664-72.
doi: 10.1074/jbc.M110.131235. Epub 2010 Jul 2.

Association between the herpes simplex virus-1 DNA polymerase and uracil DNA glycosylase

Affiliations

Association between the herpes simplex virus-1 DNA polymerase and uracil DNA glycosylase

Federica Bogani et al. J Biol Chem. .

Abstract

Herpes simplex virus-1 (HSV-1) is a large dsDNA virus that encodes its own DNA replication machinery and other enzymes involved in DNA transactions. We recently reported that the HSV-1 DNA polymerase catalytic subunit (UL30) exhibits apurinic/apyrimidinic and 5'-deoxyribose phosphate lyase activities. Moreover, UL30, in conjunction with the viral uracil DNA glycosylase (UL2), cellular apurinic/apyrimidinic endonuclease, and DNA ligase IIIalpha-XRCC1, performs uracil-initiated base excision repair. Base excision repair is required to maintain genome stability as a means to counter the accumulation of unusual bases and to protect from the loss of DNA bases. Here we show that the HSV-1 UL2 associates with the viral replisome. We identified UL2 as a protein that co-purifies with the DNA polymerase through numerous chromatographic steps, an interaction that was verified by co-immunoprecipitation and direct binding studies. The interaction between UL2 and the DNA polymerase is mediated through the UL30 subunit. Moreover, UL2 co-localizes with UL30 to nuclear viral prereplicative sites. The functional consequence of this interaction is that replication of uracil-containing templates stalls at positions -1 and -2 relative to the template uracil because of the fact that these are converted into non-instructional abasic sites. These findings support the existence of a viral repair complex that may be capable of replication-coupled base excision repair and further highlight the role of DNA repair in the maintenance of the HSV-1 genome.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Co-purification of HSV-1 DNA polymerase and uracil DNA glycosylase. A, fractions eluting from the Resource Q column were resolved by 10% SDS-PAGE followed by silver staining. The positions of markers (ML and MH, Bio-Rad low and high range standards, respectively), UL30 and UL42 are as indicated. X indicates the position of an ∼36-kDa polypeptide. B, the specified fractions were assayed for pol (●) and UDG (○) activities as described under “Experimental Procedures.”
FIGURE 2.
FIGURE 2.
Co-immunoprecipitation of UL30 with UL2. Transfection, immunoprecipitation with anti-V5, and immunoblotting were performed as described under “Experimental Procedures.” A and B, co-immunoprecipitation of UL30 with UL2 in transfected cells. Aliquots of the indicated input fractions (Input; lanes 1-7) and immunoprecipitates (IP; lanes 8-14) were probed with combined anti-UL30/UL42 rabbit antisera (A) or anti-V5 (B). C and D, co-immunoprecipitation of purified UL30 with purified UL2. Aliquots of the indicated immunoprecipitates (IP; lanes 1-3) and supernatants (Supernatant; lanes 4-6) were probed with anti-UL30 rabbit serum (C) or anti-V5 (D). The combinations of proteins are indicated, as are the positions of UL30, UL42, UL2-V5, UL2-Trx-V5, and LacZ-V5. LacZ-V5 was included as a nonspecific control and used to balance the total amount of DNA in the transfections.
FIGURE 3.
FIGURE 3.
Purified UL2 binds to immobilized UL30. Purified UL2-Trx-V5 was applied to UL30 (lanes 1-4) or aldolase beads (lanes 6-9) as described under “Experimental Procedures.” Flow-through (FT), and consecutive 1 m NaCl eluates (E1, E2, and E3) were analyzed by immunoblotting using anti-V5. The position of UL2-Trx-V5 is as indicated. M (lane 5), purified UL2-Trx-V5 control.
FIGURE 4.
FIGURE 4.
Co-immunoprecipitation of pol with UL2 in HSV-1-infected cells. Transfection, infection, immunoprecipitation, and immunoblotting were performed as described under “Experimental Procedures.” A–C, immunoprecipitation with anti-V5. A, immunoprecipitates probed with a combined anti-UL30/UL42 rabbit serum. B, input fractions probed with combined anti-UL30/UL42 rabbit sera. C, input fractions probed with anti-V5. For each panel, lane 1 represents aliquots of immunoprecipitates (A) or inputs (B and C) from cells transfected with LacZ-V5 and superinfected with HSV-1. Lane 2 represents aliquots of immunoprecipitates (A) or inputs (B and C) from cells transfected with UL2-V5 and mock-infected with HSV-1. Lane 3 represents aliquots of immunoprecipitates (A) or inputs (B and C) from cells transfected with UL2-V5 and superinfected with HSV-1. D and E, immunoprecipitation with anti-UL42 serum. D, aliquots of the indicated input fractions (Input; lanes 1 and 2) and immunoprecipitates (IP; lanes 3 and 4) were probed with anti-V5. E, aliquots of HSV-1-infected (lane 1) and mock-infected (lane 2) input fractions were probed with combined anti-UL30/UL42 rabbit sera. Infection with HSV-1 is indicated with a +. The positions of UL30, UL42, LacZ-V5, and UL2-V5 are as indicated.
FIGURE 5.
FIGURE 5.
UDG activity in HSV-1-infected cell extract binds to immobilized UL30. Two hundred-μl aliquots of extract from HSV-1-infected cells were applied to aldolase (lanes 4 and 5) or UL30 (lanes 6 and 7) beads, and the input (I), flow-through (FT), and 1 m NaCl eluates (E) were assayed for UDG activity using 4 nm 5′-32P labeled PBAZ7 as described under “Experimental Procedures.” S, substrate; B, substrate with buffer. The positions of 31-mer substrate and 16-mer product are as indicated. The numbers in italics below each lane represent the percentage of cleavage of substrate. The asterisk denotes the position of the 5′ [32P] label.
FIGURE 6.
FIGURE 6.
Co-localization of UL30 and UL2 to viral prereplicative sites. Indirect immunofluorescence microscopy of transfected cells was performed as described under “Experimental Procedures.” D, DAPI staining; R, red fluorescence (UL30); G, green fluorescence (UL2); M, merged red/green fluorescence. A, cells transfected with UL30. B, cells transfected with UL2. C and D, cells transfected with UL30, the remaining six essential viral replication proteins, oriS-containing plasmid, and PAA treatment. E–H, cells transfected with UL2, UL30, the remaining six essential viral replication proteins, oriS-containing plasmid, and PAA treatment.
FIGURE 7.
FIGURE 7.
Template uracil does not affect DNA synthesis by UL30. Primer extension reactions were performed with 4 nm UL30 for the times indicated on either the T-containing (lanes 1–6) or the U-containing templates (lanes 7–12) as described under “Experimental Procedures.” A, reaction products. Lanes 1-6 and 7-12, 0, 0.5, 1, 2, 5, and 10 min of incubation. The positions of primer and full-length product and the relevant sequence of the template are as indicated. The asterisk denotes the position of the 5′ [32P] label. B, quantitation of the data from three independent experiments. ●, T-containing template; ○, U-containing template. Error bars indicate S.E.
FIGURE 8.
FIGURE 8.
UL2 causes UL30 to stall upstream of a template uracil. Primer extension reactions were performed with 4 nm UL30 and the indicated concentrations of UL2 on either the T-containing (lanes 1–7) or the U-containing templates (lanes 8–14) as described under “Experimental Procedures.” A, primer extension reactions. Lanes 1 and 8, substrate only; lanes 2-7 and 9-14, reactions with 0, 2, 4, 6, 8, and 16 nm UL2. B, UDG activity of UL2 was assayed using the 5′-32P labeled 31-mer as described under “Experimental Procedures.” Lanes 1-6, 0, 2, 4, 6, 8, and 16 nm UL2. The positions of primer, full-length product, 31-mer substrate, and 16-mer product are as indicated. The asterisk denotes the position of the 5′ [32P] label. C, quantitation of the fraction of primers stalled upstream (positions −1 and −2) of template T (●) or U (○) from the data in A. D, quantitation of the data shown in B.
FIGURE 9.
FIGURE 9.
DNA polymerase from HSV-1-infected cells stalls upstream of template uracil. Primer extension reactions were performed with the indicated concentration of HSV-1 DNA polymerase-UL2 complex purified from HSV-1-infected cells on either the T-containing (lanes 1–6) or the U-containing templates (lanes 7–12) as described under “Experimental Procedures.” A, primer extension reactions. Lanes 1-6 and 7-12, reactions with 0, 5, 10, 25, 50, and 100 nm protein. B, UDG activity of UL2 was assayed using the 5′-32P labeled 31-mer as described under “Experimental Procedures.” Lanes 1-6, 0, 5, 10, 25, 50, and 100 nm protein. The positions of primer, full-length product, 31-mer substrate, and 16-mer product are as indicated. The asterisk denotes the position of the 5′ [32P] label. C, quantitation of the data in A. Filled symbols, T-containing templates; open symbols, U-containing templates. ●, ○, total extension; ■, □, extension beyond template T or U; ▴, ▵, stalling upstream (positions −1 and −2) of template T or U. D, quantitation of the data shown in B.

Similar articles

Cited by

References

    1. Boehmer P. E., Nimonkar A. V. (2003) IUBMB Life 55, 13–22 - PubMed
    1. Boehmer P. E., Villani G. (2003) Prog. Nucleic Acid Res. Mol. Biol. 75, 139–171 - PubMed
    1. Knipe D. M., Cliffe A. (2008) Nat. Rev. Microbiol. 6, 211–221 - PubMed
    1. McGeoch D. J., Dalrymple M. A., Dolan A., McNab D., Perry L. J., Taylor P., Challberg M. D. (1988) J. Virol. 62, 444–453 - PMC - PubMed
    1. Wu C. A., Nelson N. J., McGeoch D. J., Challberg M. D. (1988) J. Virol. 62, 435–443 - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources